83 related articles for article (PubMed ID: 21947346)
1. Tumor suppressor p53 down-regulates expression of human leukocyte marker CD43 in non-hematopoietic tumor cells.
Kadaja-Saarepuu L; Lõoke M; Balikova A; Maimets T
Int J Oncol; 2012 Feb; 40(2):567-76. PubMed ID: 21947346
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte marker CD43 promotes cell growth in co-operation with β-catenin in non-hematopoietic cancer cells.
Balikova A; Jääger K; Viil J; Maimets T; Kadaja-Saarepuu L
Int J Oncol; 2012 Jul; 41(1):299-309. PubMed ID: 22576689
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of leukocyte marker CD43 causes activation of the tumor suppressor proteins p53 and ARF.
Kadaja L; Laos S; Maimets T
Oncogene; 2004 Apr; 23(14):2523-30. PubMed ID: 14676827
[TBL] [Abstract][Full Text] [Related]
4. CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF.
Kadaja-Saarepuu L; Laos S; Jääger K; Viil J; Balikova A; Lõoke M; Hansson GC; Maimets T
Oncogene; 2008 Mar; 27(12):1705-15. PubMed ID: 17891181
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS
Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
8. Histone modifications affect differential regulation of TGFβ- induced NADPH oxidase 4 (NOX4) by wild-type and mutant p53.
Boudreau HE; Ma WF; Korzeniowska A; Park JJ; Bhagwat MA; Leto TL
Oncotarget; 2017 Jul; 8(27):44379-44397. PubMed ID: 28574838
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of mitotic checkpoint gene MAD1 by p53.
Chun AC; Jin DY
J Biol Chem; 2003 Sep; 278(39):37439-50. PubMed ID: 12876282
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina.
Wallace DM; Cotter TG
J Neurosci Res; 2009 Mar; 87(4):887-905. PubMed ID: 18951482
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of human leukosialin (CD43) gene by Sp1 through binding to a GGGTGG motif.
Kudo S; Fukuda M
Eur J Biochem; 1994 Jul; 223(2):319-27. PubMed ID: 8055899
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
[TBL] [Abstract][Full Text] [Related]
14. hnRNP-K and Pur(alpha) act together to repress the transcriptional activity of the CD43 gene promoter.
Da Silva N; Bharti A; Shelley CS
Blood; 2002 Nov; 100(10):3536-44. PubMed ID: 12411317
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor Sox4 is required for PUMA-mediated apoptosis induced by histone deacetylase inhibitor, TSA.
Jang SM; Kang EJ; Kim JW; Kim CH; An JH; Choi KH
Biochem Biophys Res Commun; 2013 Aug; 438(2):445-51. PubMed ID: 23916609
[TBL] [Abstract][Full Text] [Related]
16. Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region.
Liang Y; Zeng J; Jelicks L; Ma S; Liu J; Mei J; Perez-Soler R; Zou Y
Curr Cancer Drug Targets; 2017; 17(2):169-176. PubMed ID: 27029827
[TBL] [Abstract][Full Text] [Related]
17. DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter.
St Clair S; Giono L; Varmeh-Ziaie S; Resnick-Silverman L; Liu WJ; Padi A; Dastidar J; DaCosta A; Mattia M; Manfredi JJ
Mol Cell; 2004 Dec; 16(5):725-36. PubMed ID: 15574328
[TBL] [Abstract][Full Text] [Related]
18. Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.
Maeda Y; Hwang-Verslues WW; Wei G; Fukazawa T; Durbin ML; Owen LB; Liu X; Sladek FM
Biochem J; 2006 Dec; 400(2):303-13. PubMed ID: 16895524
[TBL] [Abstract][Full Text] [Related]
19. Histone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells through p53 Signaling Pathway Activation.
Deng Z; Liu X; Jin J; Xu H; Gao Q; Wang Y; Zhao J
Int J Biol Sci; 2016; 12(11):1298-1308. PubMed ID: 27877082
[No Abstract] [Full Text] [Related]
20. Histone deacetylase inhibitor quisinostat activates caspase signaling and upregulates p53 acetylation to inhibit the proliferation of HepG2 cells.
Li F; Wang T; Wang Z; Chen X; Liu R
Mol Med Rep; 2017 Nov; 16(5):6094-6101. PubMed ID: 28849080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
